Entering text into the input field will update the search result below

Labcorp sees up to 90% decline in COVID testing revenue in 2023

Feb. 16, 2023 10:35 AM ETLaboratory Corporation of America Holdings (LH)By: Dulan Lokuwithana, SA News Editor

Labcorp patient service center in San Francisco Bay

Sundry Photography/iStock Editorial via Getty Images

Labcorp (NYSE:LH) posted its fourth consecutive quarterly revenue decline on Thursday, estimating up to a 90% decline in its COVID testing revenue this year amid the waning pandemic impact.

However, the company’s 2023 earnings guidance

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About LH

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Laboratory Corporation of America Holdings
Fresenius SE & Co. KGaA
Quest Diagnostics Incorporated
Fresenius Medical Care AG & Co. KGaA
DaVita Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.